8,581 research outputs found
PRODUCT COMPLEMENTARITY IN PRODUCTION: THE BY-PRODUCT CASE
Production Economics,
Recommended from our members
Bayesian latent time joint mixed-effects model of progression in the Alzheimer's Disease Neuroimaging Initiative.
IntroductionWe characterize long-term disease dynamics from cognitively healthy to dementia using data from the Alzheimer's Disease Neuroimaging Initiative.MethodsWe apply a latent time joint mixed-effects model to 16 cognitive, functional, biomarker, and imaging outcomes in Alzheimer's Disease Neuroimaging Initiative. Markov chain Monte Carlo methods are used for estimation and inference.ResultsWe find good concordance between latent time and diagnosis. Change in amyloid positron emission tomography shows a moderate correlation with change in cerebrospinal fluid tau (ρ = 0.310) and phosphorylated tau (ρ = 0.294) and weaker correlation with amyloid-β 42 (ρ = 0.176). In comparison to amyloid positron emission tomography, change in volumetric magnetic resonance imaging summaries is more strongly correlated with cognitive measures (e.g., ρ = 0.731 for ventricles and Alzheimer's Disease Assessment Scale). The average disease trends are consistent with the amyloid cascade hypothesis.DiscussionThe latent time joint mixed-effects model can (1) uncover long-term disease trends; (2) estimate the sequence of pathological abnormalities; and (3) provide subject-specific prognostic estimates of the time until onset of symptoms
Coherent Emission from Magnetars
It is proposed that magnetospheric currents above the surfaces of magnetars
radiate coherent emission in analogy to pulsars. Scaling the magnetospheric
parameters suggests that the coherent emission from magnetars would emerge in
the infra-red or optical
Hard Burst Emission from the Soft Gamma Repeater SGR 1900+14
We present evidence for burst emission from SGR 1900+14 with a power-law high
energy spectrum extending beyond 500 keV. Unlike previous detections of high
energy photons during bursts from SGRs, these emissions are not associated with
high-luminosity burst intervals. Not only is the emission hard, but the spectra
are better fit by Band's GRB function rather than by the traditional
optically-thin thermal bremsstrahlung model. We find that the spectral
evolution within these hard events obeys a hardness/intensity anti-correlation.
Temporally, these events are distinct from typical SGR burst emissions in that
they are longer (~ 1 s) and have relatively smooth profiles. Despite a
difference in peak luminosity of > 1E+11 between these bursts from SGR 1900+14
and cosmological GRBs, there are striking temporal and spectral similarities
between the two kinds of bursts, aside from spectral evolution. We outline an
interpretation of these events in the context of the magnetar model.Comment: 11 pages (text and figures), submitted to ApJ Letters, corrected
erroneous hardness ratio
Recommended from our members
Neuroanatomical spread of amyloid β and tau in Alzheimer's disease: implications for primary prevention.
With recent advances in our understanding of the continuous pathophysiological changes that begin many years prior to symptom onset, it is now apparent that Alzheimer's disease cannot be adequately described by discrete clinical stages, but should also incorporate the continuum of biological changes that precede and underlie the clinical representation of the disease. By jointly considering longitudinal changes of all available biomarkers and clinical assessments, variation within individuals can be integrated into a single continuous measure of disease progression and used to identify the earliest pathophysiological changes. Disease time, a measure of disease severity, was estimated using a Bayesian latent time joint mixed-effects model applied to an array of imaging, biomarker and neuropsychological data. Trajectories of regional amyloid β and tau PET uptake were estimated as a function of disease time. Regions with early signs of elevated amyloid β uptake were used to form an early, focal composite and compared to a commonly used global composite, in a separate validation sample. Disease time was estimated in 279 participants (183 cognitively unimpaired individuals, 61 mild cognitive impairment and 35 Alzheimer's disease dementia patients) with available amyloid β and tau PET data. Amyloid β PET uptake levels in the posterior cingulate and precuneus start high and immediately increase with small increases of disease time. Early elevation in tau PET uptake was found in the inferior temporal lobe, amygdala, banks of the superior temporal sulcus, entorhinal cortex, middle temporal lobe, inferior parietal lobe and the fusiform gyrus. In a separate validation sample of 188 cognitively unimpaired individuals, the early, focal amyloid β PET composite showed a 120% increase in the accumulation rate of amyloid β compared to the global composite (P < 0.001), resulting in a 60% increase in the power to detect a treatment effect in a primary prevention trial design. Ordering participants on a continuous disease time scale facilitates the inspection of the earliest signs of amyloid β and tau pathology. To detect early changes in amyloid β pathology, focusing on the earliest sites of amyloid β accumulation results in more powerful and efficient study designs in early Alzheimer's disease. Targeted composites could be used to re-examine the thresholds for amyloid β-related study inclusion, especially as the field shifts to focus on primary and secondary prevention. Clinical trials of anti-amyloid β treatments may benefit from the use of focal composites when estimating drug effects on amyloid β and tau changes in populations with minimal amyloid β and tau pathology and limited expected short-term accumulation
The relative efficiency of time-to-progression and continuous measures of cognition in presymptomatic Alzheimer's disease.
IntroductionClinical trials on preclinical Alzheimer's disease are challenging because of the slow rate of disease progression. We use a simulation study to demonstrate that models of repeated cognitive assessments detect treatment effects more efficiently than models of time to progression.MethodsMultivariate continuous data are simulated from a Bayesian joint mixed-effects model fit to data from the Alzheimer's Disease Neuroimaging Initiative. Simulated progression events are algorithmically derived from the continuous assessments using a random forest model fit to the same data.ResultsWe find that power is approximately doubled with models of repeated continuous outcomes compared with the time-to-progression analysis. The simulations also demonstrate that a plausible informative missing data pattern can induce a bias that inflates treatment effects, yet 5% type I error is maintained.DiscussionGiven the relative inefficiency of time to progression, it should be avoided as a primary analysis approach in clinical trials of preclinical Alzheimer's disease
Hadronic decay of a scalar B meson from the lattice
We explore the transitions B to B and B to B K from
lattice QCD with flavours of sea quark, using the static approximation
for the heavy quark. We evaluate the effective coupling constants, predicting a
B to B width of around 160 MeV. Our result for the coupling
strength adds to the evidence that the B meson is not predominantly a
molecular state (BK).Comment: 10 pages LATE
- …